IL-27
Showing 1 - 25 of 6,277
A Biomarker Predicating Early Onset Neonatal Sepsis
Recruiting
- Neonatal Sepsis, Early-Onset
- IL27, PCT, CRP, Blood culture
-
Abu Dhabi, United Arab EmiratesMansoura University Children Hospital
Oct 18, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- +6 more
-
Los Angeles, California
- +3 more
Nov 16, 2022
Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United
Recruiting
- Advanced Solid Tumor
- +3 more
-
Duarte, California
- +22 more
Aug 17, 2022
Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis
Not yet recruiting
- Rheumatoid Arthritis
- (no location specified)
Oct 4, 2022
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric
Active, not recruiting
- Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
- +3 more
- zolbetuximab
- +4 more
-
Phoenix, Arizona
- +219 more
Aug 16, 2022
Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain
Recruiting
- Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
- Quantitative Real Time Polymerase chain reaction (qRT-PCR)
- ELISA and colorimeter
-
Assiut, EgyptBiochemistry department,Faculty of medicine
Oct 10, 2023
Diabetes, Type 2 Trial in Wasit (Colostrum Capsule 500 mg (Colostrum® 500 mg Veg Capsules, nowfoods®, Illinois, USA), Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- Colostrum Capsule 500 mg (Colostrum® 500 mg Veg Capsules, nowfoods®, Illinois, USA)
- Placebo
-
Wasit, IraqAl-Zahraa Teaching Hospital
Aug 22, 2023
Myeloma Trial in Houston (Fludarabine phosphate, Cyclophosphamide, NY-ESO-1 TCR/IL-15 NK)
Not yet recruiting
- Myeloma
- Fludarabine phosphate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 27, 2023
Early Disease Onset Trial (Puva (psoralin and uva ))
Not yet recruiting
- Early Disease Onset
- Puva (psoralin and uva )
- (no location specified)
Sep 27, 2023
Autoantibodies, Interleukin-6 Trial in Frederiksberg (Oral Glucose Tolerance Test, Cycling test)
Recruiting
- Autoantibodies
- Interleukin-6
- Oral Glucose Tolerance Test
- Cycling test
-
Frederiksberg, DenmarkFrederiksberg Hospital
May 10, 2023
Diagnostic and Prognostic Biomarkers for IgG4-related Disease.
Recruiting
- Immunoglobulin G4-Related Disease
- blood test
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Jun 12, 2023
Diabetes, Periodontitis, Melatonin Trial in Rize (Melatonin 3 MG)
Completed
- Diabetes Mellitus
- +3 more
- Melatonin 3 MG
-
Rize, TurkeyYagmur Sarac Gul
May 18, 2023
DuringEuploid Frozen Embryo Transfer inNatural Cycle
Not yet recruiting
- Infertility, Female
- Endometrin 100Mg Vaginal Insert
- Estradiol Valerate
-
Abu Dhabi, United Arab EmiratesART Fertility Clinics LLC
Jul 22, 2022
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR
Not yet recruiting
- Pericarditis
- IL1RA Antibody Assay
- suPAR Testing
-
Homburg, Germany
- +8 more
Jun 22, 2023
Pulmonary Immune Cell-microbiome Interactions in Healthy Lung
Recruiting
- Healthy
- Bronhcoalvelar lavage
-
Hvidovre, DenmarkHvidovre Hospital, University of Copenhagen
Apr 27, 2023
Keloid, Stem Cell Trial in Jakarta Pusat (umbilical cord-derived mesenchymal stem cells (UC-MSC), umbilical cord-derived
Completed
- Keloid
- Stem Cell
- umbilical cord-derived mesenchymal stem cells (UC-MSC)
- +2 more
-
Jakarta Pusat, DKI Jakarta, IndonesiaRSPAD Gatot Soebroto
Jul 1, 2023
Physical Activity, Resistance Exercise, Inflammation Trial in Culiacán (Resistance exercise training plus hypocaloric diet,
Recruiting
- Physical Activity
- +3 more
- Resistance exercise training plus hypocaloric diet
- Hypocaloric diet
-
Culiacán, Sinaloa, MexicoAutonomous University of Sinaloa
Jul 28, 2022
Scleroderma, Systemic Trial in Athens (MABp1 (Bermekimab) OR Placebo, MABp1 (Bermekimab))
Completed
- Scleroderma, Systemic
- MABp1 (Bermekimab) OR Placebo
- MABp1 (Bermekimab)
-
Athens, Attiki, Greece
- +1 more
Sep 28, 2022
Patients Receiving Biotherapies Targeting IL-23/IL-17 Axis in
Recruiting
- Psoriasis
- Blood sample
- +2 more
-
Paris, Ile De France, FranceLars ROGGE
Oct 6, 2022
Metastatic Renal Cell Carcinoma Trial in Boston (HD IL2)
Completed
- Metastatic Renal Cell Carcinoma
- HD IL2
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jun 20, 2022
Endodontically Treated Teeth Trial in Cairo (Intracanal Diode laser irradiation, Placebo)
Completed
- Endodontically Treated Teeth
- Intracanal Diode laser irradiation
- Placebo
-
Cairo, EgyptFaculty of Dentistry
Nov 15, 2022
IL6&8 in Malnourished Children With Acute Diarrhea
Not yet recruiting
- Acute Diarrhea
- +2 more
- Evaluation of serum levels of IL-6 and IL-8
-
Sohag, EgyptSohag University Hospital
Dec 21, 2021
Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,
Recruiting
- Colorectal Cancer
- +11 more
- Vactosertib
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023
IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.
Withdrawn
- Critical Illness Sepsis, Severe
- (no location specified)
Jun 13, 2022
MDD Trial (Tocilizumab, Placebo, Whole-Body Hyperthermia)
Not yet recruiting
- Major Depressive Disorder
- Tocilizumab
- +2 more
- (no location specified)
Aug 23, 2022